Adoption of share incentive scheme
Filed with HKEX · Stock code 6086 · · 10 pages · English
Fangzhou Inc. 方舟云康控股有限公司 (A company incorporated in the Cayman Islands with limited liability) (Stock code: 6086) ADOPTION OF SHARE INCENTIVE SCHEME ADOPTION OF THE SCHEME The Board is pleased to announce that on September 27, 2026, the Company adopted the Scheme, which is a scheme funded solely by the existing Shares and will not involve the issue of any new Shares and shall be valid and effectiv
Earlier from Fangzhou
- Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner
- 2026 Interim Report
- Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
- Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
- Fangzhou Inc. Appoints Healthcare Industry Veteran Wang Haijiao as Chief Executive Officer Following a Year of Record Growth and Profitability
Later from Fangzhou
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
Follow Fangzhou into a list and get an email when it puts out news.
Follow Fangzhou